Johnson & Johnson (BUE:JNJ) Ending Cash Position : ARS24,346,050 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Johnson & Johnson Ending Cash Position?

Johnson & Johnson's Ending Cash Position for the quarter that ended in Dec. 2024 was ARS24,346,050 Mil.

Johnson & Johnson's quarterly Ending Cash Position declined from Jun. 2024 (ARS22,278,249 Mil) to Sep. 2024 (ARS18,990,989 Mil) but then increased from Sep. 2024 (ARS18,990,989 Mil) to Dec. 2024 (ARS24,346,050 Mil).

Johnson & Johnson's annual Ending Cash Position increased from Dec. 2022 (ARS2,368,391 Mil) to Dec. 2023 (ARS7,891,099 Mil) and increased from Dec. 2023 (ARS7,891,099 Mil) to Dec. 2024 (ARS24,346,050 Mil).

Johnson & Johnson Ending Cash Position Historical Data

The historical data trend for Johnson & Johnson's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Ending Cash Position Chart

Johnson & Johnson Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

1,138,099.26

1,463,042.10

2,368,391.48

7,891,099.01

24,346,050.24

Johnson & Johnson Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															7,891,099.01	21,461,002.87	22,278,248.68	18,990,989.17	24,346,050.24

Johnson & Johnson Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Johnson & Johnson's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	22077590.221	+	2268460.022
	=	24,346,050

Johnson & Johnson's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	20179800.201	+	4166250.042
	=	24,346,050

Johnson & Johnson Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Johnson & Johnson Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (BUE:JNJ) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

JNJ:USA JNJ:Peru JNJ:Mexico JNJ_KZ:Kazakhstan 1JNJ:Italy JNJd:UK 0R34:UK JNJ0:Germany JNJ:Germany JNJ:Germany JNJ:Germany JNJ:Germany JNJ:Canada JNJB34:Brazil JNJ:Bulgaria JNJ:Austria

Address

One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933

Website

https://www.jnj.com

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.